Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

AUTL

8 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in Autolus Therapeutics plc

Yes. JPMorgan Chase holds 913,239 shares of AUTL (Autolus Therapeutics), worth $1.5M, as of its Q2 2026 13F filing. It reduced the position by 22,164 shares (-2.4%) from Q1 2026. JPMorgan Chase has held AUTL in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$1.5M

Current Shares

913,239

Total Value Change

-$3.2M

Total Shares Change

-371,469

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
913,239
-2.4%
$1.5M0.0%$1.60
0
2026-Q1
Decreased
935,403
-4.5%
$1.2M0.0%$1.62
0
2025-Q4
Increased
979,275
+8.4%
$1.9M0.0%$1.97
28
2025-Q3
Decreased
903,068
-1.3%
$1.5M0.0%$1.63
0
2025-Q2
Decreased
914,743
-35.1%
$2.1M0.0%$2.28
0
2025-Q1
Increased
1.4M
+31.6%
$2.2M0.0%$1.55
33
2024-Q4
Decreased
1.1M
-16.6%
$2.5M0.0%$2.35
0
2024-Q3
First report
1.3M
-
$4.7M0.0%$3.63
0

Other major holders of AUTL: Blackstone Inc., Wellington Management Group LLP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used